QA: Cornerstone Therapeutics INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001145404_2012_Cornerstone_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001145404, Cornerstone Therapeutics INC

  xvar xval
0 AssetsCurrent 107,048,000
1 IntangibleAssetsNetIncludingGoodwill 122,178,000
2 PropertyPlantAndEquipmentNet 1,574,000
3 remainder_Assets 1,514,000
4 LiabilitiesCurrent 48,655,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 8,856,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 46,344,000
9 ResearchAndDevelopmentExpense 1,624,000
10 remainder_Expenses 54,019,000
11 remainder_Revenues 101,422,000
12 remainder_NetIncome -128,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 232,314,000
1 Liabilities 57,511,000
2 Expenses 101,987,000
3 Revenues 101,422,000
4 StockholdersEquity 174,803,000
5 NetIncome -693,000
6 ComprehensiveNetIncome -693,000
7 BaseVar 246,681,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.62
9 EconomicCapitalRatio 3.44

Edgar->Model Mapping

Feature Distribution